Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
Sales | 3,556,300 | 3,376,900 | 3,465,500 | 3,139,400 | 3,088,200 |
Cost of Goods | 796,400 | 751,700 | 731,500 | 679,300 | 643,000 |
Gross Profit | 2,759,900 | 2,625,200 | 2,734,001 | 2,460,100 | 2,445,200 |
Operating Expenses | 1,854,800 | 2,073,500 | 1,844,700 | 1,531,800 | 1,585,800 |
Operating Income | 905,500 | 552,400 | 889,801 | 928,600 | 859,400 |
Interest Expense | 7,500 | 9,300 | 9,800 | 15,800 | 19,900 |
Other Income | -59,800 | 72,400 | 83,999 | 3,100 | 48,400 |
Pre-tax Income | 838,200 | 615,500 | 964,000 | 915,900 | 887,900 |
Income Tax | 181,300 | 215,100 | 216,800 | 201,500 | 195,700 |
Net Income Continuous | 656,900 | 400,400 | 747,200 | 714,400 | 692,200 |
Net Income | $656,900 | $400,400 | $747,200 | $714,400 | $692,200 |
EPS Basic Total Ops | 0.61 | 0.37 | 0.70 | 0.66 | 0.64 |
EPS Basic Continuous Ops | 0.61 | 0.37 | 0.70 | 0.66 | 0.64 |
EPS Diluted Total Ops | 0.60 | 0.37 | 0.69 | 0.66 | 0.64 |
EPS Diluted Continuous Ops | 0.60 | 0.37 | 0.69 | 0.66 | 0.64 |
EBITDA(a) | $1,055,500 | $700,000 | $996,400 | $1,081,900 | $1,003,400 |